最新一集 🔗
Dr Golfinopoulos meets with ecancertv at IBCD 2016 to discuss SPECTA: a screening platform that sought to encourage patients to participate in clinical trials.
He describes how regulatory involvement in trial design and drug design could be streamlined, and the issue of reimbursement for personali…
以前的節目 🔗
Dr Malik speaks with ecancertv at IBCD 2016 to discuss the work of the National Cancer Institute in recruiting patients to clinical trials when subtyping limits disease-wide enrollment.
She describes how 'exceptional responders' can be referred to the NCI for genotyping, and schemes to match patie…
Dr Beer speaks with ecancertv at IBCD 2016 about making use of genomic data in a clinically actionable setting.
He opens with comments on the work of Dr Moritz Gerstung and considers the issues of storage, access and regulation in genomic libraries.
Dr Beer describes how unregulated access and of…
Dr Schneider speaks with ecancertv at IBCD 2016 about the regulatory checkpoints to be passed in the development of assays.
He highlights the difference in reproducibility and robustness of research and clinical assays, the clinical utility of validated biomarkers, and how beginning assay developm…
Dr Lacombe speaks with ecancertv at IBCD 2016 about the role of the conference in communicating advances in drug development.
He describes the presentations given during a session he chaired at the conference, including the research of Dr Shakun Malik and Dr Vassilis Golfinopoulos.
Considering un…
Prof van Dongen speaks with ecancertv at IBCD 2016 about gaining deeper insight into drug action and suitability with radiolabelling.
He describes how the journey of radiolabelled ligands may steer drug development, aiming for biomarkers and accumulating in tumours with localised tissue damage and…
Dr Gerstung speaks with ecancertv at IBCD 2016 about genetic analysis of AML patients that has contributed to a predictive model for treatment risk and outcomes.
He describes how modelling can be improved with wider data gathering, across populations and tumour types, though this faces the risk of…
Dr Lively joins ecancer at IBCD 2016 to discuss presentations from the conference session she chaired.
She discusses the work of Dr Simon Dovedi in developing assays for immune therapy, of Dr Robert Kinders in reproducibility and relevance of assays for clinical trials.
Dr Lively reflects on the …
Dr Vietz speaks with ecancertv at IBCD 2016 about the regulatory requirements and quality controls necessary for genomic profiling.
She describes her work in constructing consistent, up to date guidelines for genomic assays, and considers balancing cost of access against comprehensive genetic test…
Dr Hewitt speaks with ecancertv at IBCD 2016 about development of assays for predictive biomarkers as a part of personalised therapy.
The use of biomarkers he describes could help with the selection of the most effective treatment for patients, depending on gene expression within tumours, and impo…
免責聲明: 本頁面嵌入的 Podcast 和封面圖片來自 ecancer.org，歸其所有者所有，與 Listen Notes, Inc. 無關聯，也未獲得 Listen Notes, Inc. 背書。
Podcast 搜尋引擎
您可以使用我們的網站按人物、地點或主題搜尋3,832,198Podcast 和196,939,749單集。
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
認領這個 Podcast
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post 分類廣告 for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
Podcast 創作者訪談...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
我們的官方 X（原 Twitter）帳戶 will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
